- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
An App for Aspirin and Other Medicine in the News
An app for aspirin, an antidote for opioids: 2 of the 6 topics in our slide show of notable studies on the Web.
Recent medical news around the Web is worth a closer look. We selected 6 studies of note to primary care and summarized them in the slides above. Topics include: a new app to identify patients appropriate for aspirin use to prevent CVD; a brief scale to identify older patients who may need help with medications; coprescription of naloxone with opioids for chronic pain, and high-quality end-of-life care for illnesses other than cancer.Find links to studies/abstracts below.
References:
New App Guides Aspirin Use for Cardiovascular Disease
Help Older Patients Who Need Help With Medications
Naloxone With Opioids Nixes ED Visits in Primary Care Settings
High-quality End-of-Life Care Needed for Illnesses Other Than Cancer
Clerical Burden of EHRs Leads to Physician Burnout
Cardiovascular Mortality Decline Has Slowed Down
Roche, Alnylam Advance Zilebesiran Into Phase 3 CV Outcomes Trial for Resistant Hypertension
September 9th 2025Zilebesiran’s twice-yearly dosing and sustained BP reductions could offer a new therapeutic approach for adults with resistant hypertension and high CV risk who are uncontrolled on current SOC regimens.
Oral PCSK9 Inhibitor Enlicitide Meets All End Points in Phase 3 Hypercholesterolemia Trial
September 2nd 2025At week 24, patients receiving once-daily enlicitide demonstrated statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol compared with placebo.
